Feature Channels: Pharmaceuticals

Filters close
Released: 23-Mar-2023 11:05 AM EDT
Big Data and AI Meet Cancer Research
University of New Mexico Comprehensive Cancer Center

Avinash Sahu, PhD, and his team leveraged artificial intelligence, machine learning, and big data to create a novel way to discover multi-function drugs. The approach used cancer research data, biological data, and transfer learning to not only find drugs with specific properties but also to predict patient responses to them.

   
17-Mar-2023 11:05 AM EDT
In Epilepsy, Higher Risk of Early Death Varies Based on Severity, Other Factors
American Academy of Neurology (AAN)

A new study has found that people with epilepsy have an increased risk of early death and the increased risk varies depending on where they live, the number of medications they take and what other diseases they may have. The study is published in the March 22, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Newswise: Study: Spice May Improve Ovarian Cancer Treatment
Released: 22-Mar-2023 3:45 PM EDT
Study: Spice May Improve Ovarian Cancer Treatment
New York Institute of Technology, New York Tech

New research makes the case for why curcumin could help enhance treatment for ovarian cancer.

   
Released: 22-Mar-2023 11:25 AM EDT
Seniors’ use of urinary-tract infection antibiotics halved
University of Gothenburg

As an international study involving University of Gothenburg researchers has shown, a decision tool for health professionals has proved capable of halving the use of antibiotics against urinary tract infections while maintaining patient safety.

Newswise: Scientists use tardigrade proteins for human health breakthrough
Released: 20-Mar-2023 7:00 PM EDT
Scientists use tardigrade proteins for human health breakthrough
University of Wyoming

University of Wyoming researchers’ study of how microscopic creatures called tardigrades survive extreme conditions has led to a major breakthrough that could eventually make life-saving treatments available to people where refrigeration isn’t possible.

Released: 20-Mar-2023 6:35 PM EDT
Advanced brain imaging study hints at how DMT psychedelic alters perception of reality
Imperial College London

In a study at Imperial College London, detailed brain imaging data from 20 healthy volunteers revealed how the potent psychedelic compound, DMT (dimethyltryptamine), alters brain function.

Not for public release

This news release is embargoed until 20-Mar-2023 5:00 PM EDT Released to reporters: 14-Mar-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-Mar-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 20-Mar-2023 4:15 PM EDT Released to reporters: 27-Jul-2022 1:40 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-Mar-2023 4:15 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

       
Released: 20-Mar-2023 9:00 AM EDT
Antibiotic resistance is an increasing problem. Learn all about it in the Drug Resistance channel.
Newswise

Staphylococcus aureus, Clostridioides difficile, Candida auris, Drug-resistant Shigella. These bacteria not only have difficult names to pronounce, but they are also difficult to fight off. These bacteria may infect humans and animals, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Antimicrobial resistance is an urgent global public health threat.

     
Released: 17-Mar-2023 2:25 PM EDT
The new insulin price cap: What you need to know
Michigan Medicine - University of Michigan

In early March, Eli Lilly made headlines after announcing a new $35 price cap on insulin for individuals with private insurance. Novo Nordisk and Sanofi made their own price reduction announcements shortly after Eli Lilly’s move.

Newswise: A New Combination Therapy Regimen Shows Promising Results for Prostate Cancer
Released: 16-Mar-2023 4:35 PM EDT
A New Combination Therapy Regimen Shows Promising Results for Prostate Cancer
University of Utah Health

The combination of two oral medications has shown positive results in people with prostate cancer, whose disease has spread to other parts of the body. Compared with XTANDI plus placebo, the investigatory combination of TALZENNA and XTANDI demonstrated a statistically significant and clinically meaningful improvement in radiographic progression-free survival.

Newswise: DNA Treatment Could Delay Paralysis That Strikes Nearly All Patients With ALS
Released: 16-Mar-2023 2:30 PM EDT
DNA Treatment Could Delay Paralysis That Strikes Nearly All Patients With ALS
University of California San Diego

UC San Diego researchers use a DNA designer drug to restore key protein levels in motor neurons, delaying paralysis in a mouse model of ALS.

Released: 16-Mar-2023 9:00 AM EDT
Ochsner Health Advances Precision Medicine, Becomes National Leader in Universal Genomic Testing for Chemotherapy
Ochsner Health

Ochsner Health is leading the way for precision medicine nationwide by becoming one of the first hospital systems to standardize genomic testing, significantly advancing ways in which care teams can treat cancer patients. This change helps providers determine individualized treatment by understanding how patients will react to certain drugs, thereby lowering risk of adverse side effects, improving patient experience, and bettering patient outcomes.

Newswise: Women with rheumatoid arthritis more likely to achieve remission if they take sex hormones
Released: 16-Mar-2023 12:05 AM EDT
Women with rheumatoid arthritis more likely to achieve remission if they take sex hormones
University of South Australia

A large study of women with rheumatoid arthritis has found that those taking oral contraceptives or hormone replacement therapy (HRT) had a greater chance of achieving remission.

Released: 15-Mar-2023 1:30 PM EDT
Aitia and UCB Announce Strategic Drug Discovery Collaboration in Huntington's Disease
Aitia

UCB, a global biopharmaceutical company, and Aitia, the leader in the application of Causal AI and "Digital Twins" to discover and develop new drugs, today announced an early drug discovery collaboration focused on the discovery and validation of novel drug targets and drug candidates for Huntington's disease.

Newswise: Antidepressant Medication May Be Key to Help People Stop Use of Cocaine While in Treatment for Opioid Use Disorder
Released: 15-Mar-2023 12:05 PM EDT
Antidepressant Medication May Be Key to Help People Stop Use of Cocaine While in Treatment for Opioid Use Disorder
Johns Hopkins Medicine

For some people receiving methadone for treatment of opioid use disorder (OUD), the co-use of opioids and stimulants such as cocaine is an issue. Now, a new study led by Johns Hopkins Medicine researchers found that bupropion, an antidepressant medication also used for smoking cessation, may help people stop using cocaine while in treatment for OUD.

14-Mar-2023 12:00 PM EDT
Targeting menin induces responses in acute leukemias with KMT2A rearrangements or NPM1 mutations
University of Texas MD Anderson Cancer Center

Researchers from The University of Texas MD Anderson Cancer Center showed that inhibiting menin with revumenib, previously known as SNDX-5613, yielded encouraging responses for advanced acute leukemias with KMT2A rearrangements or mutant NPM1. Findings from the Phase I AUGMENT-101 trial were published today in Nature.

Released: 14-Mar-2023 2:25 PM EDT
Potential Treatment Target for Drug-Resistant Epilepsy Identified
Tufts University

A new study by Tufts University researchers found a molecule that could be a target for treatment in patients who have become resistant to traditional anti-seizure drugs

   
Released: 14-Mar-2023 7:00 AM EDT
Diuretics Work Differently According to Biological Sex and Time of Treatment
American Physiological Society (APS)

A new computational study in a mouse model finds biological sex and time of day makes a difference in the effectiveness of diuretics—medications commonly prescribed to manage high blood pressure. The study is published ahead of print in the American Journal of Physiology-Renal Physiology.

Released: 14-Mar-2023 6:05 AM EDT
Penn Medicine Research Suggests More Cancers Can Be Treated with Drugs Than Previously Believed
Perelman School of Medicine at the University of Pennsylvania

Up to 50 percent of cancer-signaling proteins once believed to be immune to drug treatments due to a lack of targetable protein regions may actually be treatable, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. The findings, published this month in Nature Communications, suggest there may be new opportunities to treat cancer with new or existing drugs.

Newswise: Mountainside Medical Center Recognized for Antimicrobial Stewardship
Released: 13-Mar-2023 9:00 AM EDT
Mountainside Medical Center Recognized for Antimicrobial Stewardship
Hackensack Meridian Health (Mountainside Medical Center)

Hackensack Meridian Mountainside Medical Center has been recognized as a Silver Level Antimicrobial Stewardship Recognition Program award recipient by the NJDOH.

Newswise: New Class of Drugs Could Prevent Resistant COVID-19 Variants
Released: 10-Mar-2023 6:00 PM EST
New Class of Drugs Could Prevent Resistant COVID-19 Variants
Yale Cancer Center/Smilow Cancer Hospital

The constant evolution of new COVID-19 variants makes it critical for clinicians to have multiple therapies in their arsenal for treating drug-resistant infections. Researchers have now discovered that a new class of oral drugs that acts directly on human cells can inhibit a diverse range of pathogenic SARS-CoV-2 strains. In their newly published study, the team found a novel mechanism through which the gene that expresses angiotensin converting enzyme-2 (ACE-2)—the cellular receptor to which SARS-CoV-2 binds so that it can enter and infect the cell—is turned on.

Released: 10-Mar-2023 12:15 PM EST
Prenatal exposure to anti-nausea drug in ‘60s, ‘70s tied to increased risk of colorectal cancer
University of Texas Health Science Center at Houston

Prenatal exposure to an anti-nausea drug commonly used in the 1960s and 1970s has been shown to increase risk of colorectal cancer in adult offspring, according to a study by researchers at UTHealth Houston.

Released: 9-Mar-2023 2:45 PM EST
Reducing opioids prescribed after total knee and hip arthroplasty can be beneficial for patients and doctors
Michigan Medicine - University of Michigan

Opioids are commonly prescribed to patients that are discharged after a total knee and hip arthroplasty. Patients are typically given larger prescriptions of opioids that can result in an excess of the medication in their home after recovery is over.

Released: 9-Mar-2023 11:55 AM EST
Stuart Therapeutics, Inc. Announces Upcoming Presentations at ARVO 2023 Annual Meeting
Stuart Therapeutics

Stuart Therapeutics, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing therapies for the treatment of anterior segment, refractive and posterior segment eye disorders, today announced that it is sponsoring two research poster presentations by researchers at Vanderbilt University and the University of Rochester at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, which will take place from April 23-27, 2023, in New Orleans, Louisiana.

   
Newswise: New Class of Drugs May Prevent Infection by Wide Range of COVID-19 Variants
Released: 9-Mar-2023 11:05 AM EST
New Class of Drugs May Prevent Infection by Wide Range of COVID-19 Variants
Dana-Farber Cancer Institute

A new class of oral drugs can inhibit a wide range of SARS-CoV-2 variants, researchers report, potentially identifying new antiviral agents providing broad activity against the constantly emerging new strains of the COVID-19 virus

9-Mar-2023 10:00 AM EST
HSS Presents Research at 2023 AAOS Annual Meeting
Hospital for Special Surgery

At this year’s American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, held March 7 to 11 in Las Vegas, Hospital for Special Surgery (HSS) presented new research on a variety of topics in orthopedic surgery, including studies related to minimally invasive surgery, racial disparities, and opioid alternatives for pain management in spine care.

Released: 8-Mar-2023 12:40 PM EST
New Study: Abatacept Therapy Offers Promising Results Treating Juvenile Dermatomyositis
George Washington University

Juvenile dermatomyositis, a rare but often severe and chronic systemic autoimmune disease, includes a large number of patients who are treatment resistant, requiring long term immunosuppressive therapy. A small open-label study published in Arthritis and Rheumatology shows promise using a targeted biologic therapy called abatacept to treat such patients.

Released: 8-Mar-2023 12:20 PM EST
First nasal monoclonal antibody treatment for COVID-19 shows promise for treating virus, other diseases
Brigham and Women’s Hospital

A pilot trial by investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, tested the nasal administration of the drug Foralumab, an anti-CD3 monoclonal antibody.

28-Feb-2023 5:05 PM EST
Modifying messenger RNA may provide a new target for Alzheimer’s disease
PLOS

Reducing the methylation of a key messenger RNA can promote migration of macrophages into the brain and ameliorate symptoms of Alzheimer’s disease in a mouse model, according to a new study publishing March 7th in the open access journal PLOS Biology by Rui Zhang of Air Force Medical University in Xian, Shaanxi, China. The results illuminate one pathway for entrance of peripheral immune cells into the brain, and may provide a new target for treatment of Alzheimer’s disease.

Released: 7-Mar-2023 4:20 PM EST
FDA mandate to limit acetaminophen in acetaminophen-opioid medications is associated with reduced serious liver injury
University of Alabama at Birmingham

A United States Food and Drug Administration mandate to limit the dosage of acetaminophen in pills that combine acetaminophen and opioid medications is significantly associated with subsequent reductions in serious liver injury.

Released: 7-Mar-2023 1:05 PM EST
Brain tumor discovery paves way for new drug treatments
University of Nottingham

New research has shown that the blood vessels that feed aggressive brain tumours have receptors that could allow a new type of drug-containing nanoparticle to be used to starve the tumours of the energy they use to grow and spread, and also cause other disruptions to their adapted existence, even killing themselves.

Newswise: UT Southwestern scientists discover agent that reverses effects of intoxication
Released: 7-Mar-2023 12:40 PM EST
UT Southwestern scientists discover agent that reverses effects of intoxication
UT Southwestern Medical Center

A shot of a liver-produced hormone called FGF21 sobered up mice that had passed out from alcohol, allowing them to regain consciousness and coordination much faster than those that didn’t receive this treatment, UT Southwestern researchers report in a new study. The findings, published in Cell Metabolism, could lead to effective treatments for acute alcohol intoxication, which is responsible for about 1 million emergency room visits in the U.S. each year.

Released: 7-Mar-2023 10:05 AM EST
Cornell-developed anti-TB compound headed to trials
Cornell University

A novel compound that has the potential to starve the bacteria that causes tuberculosis – the world’s leading infectious killer after SARS-CoV2 – is entering human clinical trials.

Released: 6-Mar-2023 7:20 PM EST
The next pandemic: Researchers develop tool to identify existing drugs to use in a future outbreak
New York University

A global team of researchers has created an algorithmic tool that can identify existing drugs in order to combat future pandemics. The work, reported in the Cell Press journal Heliyon, offers the possibility of responding more quickly to public-health crises.

Released: 6-Mar-2023 5:50 PM EST
Denovo Biopharma Creates Innovative Gene Registry Program to Support the First Precision Medicine for Treatment Resistant Depression
Denovo Biopharma LLC

Denovo Biopharma LLC ("Denovo"), a pioneer in applying precision medicine to the development of innovative therapies, set up a gene registry web portal and invites people who suffer from treatment-resistant depression (TRD) to visit www.iMatchDepression.com to help identify whether they or someone they know may be eligible to participate in a biomarker-guided global Phase 2b clinical trial (the "ENLIGHTEN" study).

Released: 6-Mar-2023 3:05 PM EST
New research points to drug option for hair-pulling, skin-picking disorders
University of Chicago Medical Center

Treatment with the drug memantine was associated with significant improvements compared to a placebo for patients with trichotillomania and excoriation disorders.

Newswise: High-Dose Anticoagulation Can Reduce Intubations and Improve Survival for Hospitalized COVID-19 Patients
Released: 6-Mar-2023 12:00 PM EST
High-Dose Anticoagulation Can Reduce Intubations and Improve Survival for Hospitalized COVID-19 Patients
Mount Sinai Health System

High-dose anticoagulation can reduce deaths by 30 percent and intubations by 25 percent in hospitalized COVID-19 patients who are not critically ill when compared to the standard treatment, which is low-dose anticoagulation.

Newswise: New Research Addresses the Drug Pricing Conundrum: Encouraging Innovation While Maintaining Affordability
Released: 6-Mar-2023 4:05 AM EST
New Research Addresses the Drug Pricing Conundrum: Encouraging Innovation While Maintaining Affordability
ISPOR—The Professional Society for Health Economics and Outcomes Research

Value in Health, the official journal of ISPOR, announced the publication of a series of articles describing important new research related to drug pricing globally. The articles were published in the March 2023 issue of the journal.

Newswise: Adding antipsychotic med to antidepressant may help older adults with treatment-resistant depression
2-Mar-2023 5:35 PM EST
Adding antipsychotic med to antidepressant may help older adults with treatment-resistant depression
Washington University in St. Louis

Psychiatry researchers at Washington University School of Medicine in St. Louis, led a multicenter study that found, in older adults with treatment-resistant depression, that augmenting an antidepressant drug with aripiprazole helped a significant number of patients.

Released: 3-Mar-2023 11:05 AM EST
Researchers identify gene mutation capable of regulating pain
Sao Paulo Research Foundation (FAPESP)

Pain afflicts at least 1.5 billion people worldwide, and despite the availability of various painkilling drugs, not all forms of pain are treatable.

Released: 2-Mar-2023 4:00 PM EST
Newly identified personalized immunotherapy combination treats an aggressive form of advanced prostate cancer
University of Chicago Medical Center

A combination treatment that targets the immune system helps treat aggressive prostate cancers that don’t respond to conventional therapies.

Released: 2-Mar-2023 11:00 AM EST
Foundation for Anesthesia Education and Research Establishes Endowed NAM Fellowship
American Society of Anesthesiologists (ASA)

The Foundation for Anesthesia Education and Research (FAER) announced it has established an endowed National Academy of Medicine (NAM) fellowship to provide early-career anesthesiology scholars with the opportunity to experience and participate in committee, workshop, and roundtable activities of NAM and the National Academy of Sciences (NAS).

27-Feb-2023 9:30 AM EST
Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in Children
Mount Sinai Health System

Mount Sinai Health System and Memorial Sloan Kettering Cancer Center researchers have developed a new drug delivery approach that uses nanoparticles to enable more effective and targeted delivery of anti-cancer drugs to treat brain tumors in children.



close
3.25042